Their comment article, published last week (15 March) in the journal Nature, highlights the critical lack of new treatments for mental health disorders, to include Alzheimer’s, depression, and schizophrenia.
Professor Barbara Sahakian, of the Department of Psychiatry and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge, and Dr Thomas Insel, Director of the National Institute of Mental Health in the United States, were leaders on the comment piece after a Royal Society meeting held to address the ‘pharmacological impasse’ concluded that the lack of viable new treatments ‘calls for a fundamental change in nearly every aspect of translational research in mental health’.
Read the full story
Image: Numb Credit: Ten Thirty Nine from Flickr.
Reproduced courtesy of the University of Cambridge
___________________________